Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.
Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.
Authorities allege the pharmacy chain gave patients more insulin than prescribed and then billed Medicare and Medicaid for the full amounts. This allegedly occurred for more than a decade.
The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.
An imaging industry supplier best known for a widely adopted radiology reporting platform is partnering on radiological artificial intelligence with a company that pioneered GPUs and accelerated computing.
An established radiopharmaceutical can now be applied with the FDA’s blessing when symptoms of cognitive decline point to the second most common form of degenerative dementia (after only Alzheimer’s disease).
With its 108th scientific assembly and annual meeting a little more than two weeks away, the Radiological Society of North America is encouraging attendees to experience 2022’s big show virtually—even if they’ll be there in person.
RapidAI has been cleared for U.S. marketing of updated AI-outfitted software that quickly detects or rules out acute brain hemorrhage on unenhanced CT.
More than 30% of surveyed PACS users are looking around for a potential replacement, according to an 82-page report from KLAS. “The U.S. PACS market is poised for change," the report's authors wrote.
Contrary to older research that showed neuroimaging emerging as the single most dominating cost contributor in ischemic stroke care for older Americans, a new study shows treatment and other line items account for bigger slices of the bill.
A three-site imaging operation in Hawaii has been turning away patients since Oct. 20 due to what its management initially described as unspecified “technical difficulties.”